ArticleArquivos de neuro-psiquiatria2025
Diagnostic performance of the Brief Cognitive Screening Battery-Indonesian version in detecting cognitive impairment.
Article in Arquivos de neuro-psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuropsychological and functional assessments are crucial for identifying the transition from healthy aging to dementia. While brief cognitive batteries have become popular for their practicality, most have been developed in high-income countries, neglecting the diverse educational backgrounds found in developing nations.This study focuses on the Brief Cognitive Screening Battery (BCSB) adapted for Indonesia (BCSB-INA), aiming to investigate its diagnostic accuracy in detecting cognitive impairment among older adults.This cross-sectional study was conducted at the Memory Clinic of Universitas Sumatera Utara Hospital from January to August 2024, including participants aged 50 and above. Subjects underwent cognitive assessments using MoCA-INA and BCSB-INA. Data analysis involved ROC curves to evaluate the tests' accuracy.A total of 140 subjects were included, with significant differences in cognitive test scores between those with cognitive impairment and normal individuals. The BCSB-INA demonstrated good diagnostic performance, with an AUC of 0.875 when including the Clock Drawing Test (CDT) and 0.810 without it. The development of a multivariate model further enhances its diagnostic capabilities, allowing for more tailored intervention strategies.The BCSB-INA represents an important improvement in cognitive assessment for older adults in Indonesia, showing good sensitivity and specificity. Continued research and updates to cognitive assessment tools are crucial to meet the increasing demand for effective dementia screening in diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.